- Home
- PRO vs MDXG Comparison
PRO vs MDXG Comparison
Compare PRO & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRO
- MDXG
- Stock Information
- Founded
- PRO 1985
- MDXG 2006
- Country
- PRO United States
- MDXG United States
- Employees
- PRO N/A
- MDXG N/A
- Industry
- PRO EDP Services
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- PRO Technology
- MDXG Health Care
- Exchange
- PRO Nasdaq
- MDXG Nasdaq
- Market Cap
- PRO 863.3M
- MDXG 877.4M
- IPO Year
- PRO 2007
- MDXG N/A
- Fundamental
- Price
- PRO $14.12
- MDXG $7.04
- Analyst Decision
- PRO Strong Buy
- MDXG Strong Buy
- Analyst Count
- PRO 10
- MDXG 2
- Target Price
- PRO $28.10
- MDXG $12.00
- AVG Volume (30 Days)
- PRO 1.0M
- MDXG 996.5K
- Earning Date
- PRO 07-31-2025
- MDXG 07-30-2025
- Dividend Yield
- PRO N/A
- MDXG N/A
- EPS Growth
- PRO N/A
- MDXG N/A
- EPS
- PRO N/A
- MDXG 0.21
- Revenue
- PRO $342,708,000.00
- MDXG $363,774,000.00
- Revenue This Year
- PRO $10.27
- MDXG $9.55
- Revenue Next Year
- PRO $10.46
- MDXG $11.43
- P/E Ratio
- PRO N/A
- MDXG $33.44
- Revenue Growth
- PRO 7.96
- MDXG 6.85
- 52 Week Low
- PRO $13.61
- MDXG $5.47
- 52 Week High
- PRO $29.84
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- PRO 34.67
- MDXG 55.67
- Support Level
- PRO $14.30
- MDXG $6.91
- Resistance Level
- PRO $15.99
- MDXG $7.37
- Average True Range (ATR)
- PRO 0.81
- MDXG 0.33
- MACD
- PRO -0.14
- MDXG 0.01
- Stochastic Oscillator
- PRO 2.30
- MDXG 37.50
About PRO PROS Holdings Inc.
Pros Holdings Inc provides software solutions that optimize shopping and selling experiences for both business-to-business and business-to-consumer companies across industry verticals in more than nearly 80 countries. Its PROS Platform is designed to help businesses create, optimize and market available offers and handle orders through both first- and third-party digital channels. The firm generates key revenue form the United States of America, Germany, The rest of Europe, Africa, Asia-Pacific, and Middle East regions.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.